Higher levels of vaccine-induced circulating anti-SARS-CoV-2 S IgA after three vaccinations were associated with a reduced risk of breakthrough infection, despite no similar association with vaccine-induced anti-SARS-CoV-2 S IgG levels. This evidence concerns the gene CD79A and infection.